We had done numerous trips to UCSF when Mithil was sick with the hope that he will get better. It was a very surreal moment when, this time in December 2018 we went to UCSF to hand over a check to support DIPG research! This time to advance the findings about DIPG through clinical trials. Thanks to all our supporters who made this possible.
Our foundation has provided funds for a clinical trial - H3.3K27M specific peptide vaccine combined with poly-ICLC for the treatment of newly diagnosed HLA-A2+ H3.3K27M positive diffuse intrinsic pontine glioma (DIPG) as well as other newly diagnosed HLA-A2+ H3.3K27M-positive gliomas. For more details go to http://www.pnoc.us/clinical-trials/h33k27m-specific-peptide-vaccine-combined-poly-iclc-treatment-newly-diagnosed-hla-a2